Roche and AstraZeneca settle years long patent battle over Ultomiris — report

Roche and AstraZeneca settle years long patent battle over Ultomiris — report

Source: 
Endpoints
snippet: 

Roche’s Chugai unit and AstraZeneca’s Alexion have settled a years long patent battle over the latter’s Ultomiris — a rare blood disorder treatment designed to succeed Alexion’s blockbuster Soliris, according to reports.